Who
Douglas Love
President and CEO
Company insider
Files Form 4 as: President and CEO, Annexon.
In numbers
- Trades disclosed
- 52
- Buys
- 2
- Sells
- 10
- Bought
- $347K
- Sold
- $820K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Feb 2021
- Last trade
- 24 Sep 2026
- Last filed
- 25 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 25 Sep 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $100K26,065 at $3.83 | filing |
| 24 Sep 2026filed 25 Sep 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $100K26,065 at $3.83 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,250,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,250,000 at $0.00 | filing |
| 27 Feb 2025filed 3 Mar 2025 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,300,000 at $0.00 | filing |
| 13 Feb 2025filed 18 Feb 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $15K5,021 at $2.95 | filing |
| 6 Jan 2025filed 8 Jan 2025 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code M | —37,994 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Code M | $54K37,994 at $1.41 | filing |
| 30 Oct 2024filed 1 Nov 2024 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code M | —78,399 at $0.00 | filing |
| 30 Oct 2024filed 1 Nov 2024 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code M | —36,050 at $0.00 | filing |
| 30 Oct 2024filed 1 Nov 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Code M | $145K78,399 at $1.85 | filing |
| 30 Oct 2024filed 1 Nov 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Code M | $67K36,050 at $1.85 | filing |
| 16 Feb 2024filed 21 Feb 2024 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —656,200 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $32K5,782 at $5.54 | filing |
| 16 Feb 2023filed 21 Feb 2023 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —345,000 at $0.00 | filing |
| 15 Feb 2023filed 17 Feb 2023 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $39K6,571 at $5.87 | filing |
| 11 Jul 2022filed 13 Jul 2022 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 11 Jul 2022filed 13 Jul 2022 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 11 Jul 2022filed 13 Jul 2022 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 14 Apr 2022filed 18 Apr 2022 | ANNX AnnexonBiotechnology | SEC FORM 4 Bought | $147K60,000 at $2.45 | filing |
News
No headline names them, or the companies they trade most, lately.